Keith S. Manchester, Director at Roivant Sciences Ltd. (ROIV), sold 1,006,000 shares at $11.63 ($11.7M) on 2024-09-24, disclosed to the SEC on 2024-09-26.
Open-market sale of $11.7M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.63 | 368,052 | $4.3M | 36.5% |
| 2 | $11.63 | 368,052 | $4.3M | 36.5% |
| 3 | $11.77 | 134,948 | $1.6M | 13.5% |
| 4 | $11.77 | 134,948 | $1.6M | 13.5% |
| Total | $11.67 avg | 1,006,000 | $11.7M | 100% |
| Filing → |
| ROIV | SELL | 2025-12-18 | $71.8M | — | Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |
| ABUS | SELL | 2024-08-16 | $33K | — | Filing → |